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Bovine herpesvirus 1 (BHV-1) establishes a latent infection in sensory ganglionic neurons of infected
animals. Expression of latency-related (LR) gene products is controlled by a 980-bp fragment (LR promoter).
DNA sequence analysis revealed that two major open reading frames (ORFs) are in the LR gene. Antibodies
directed against both ORFs were generated in rabbits by using synthetic peptides. Antibody P2, which is
directed to sequences near the amino terminus of ORF 2, recognized a 41-kDa protein in lytically infected cells,
suggesting that ORF 2 encodes a protein. When the LR gene was inserted into a mammalian expression vector
and subsequently transfected into COS-7 cells, a 41-kDa protein was detected by use of silver-stained sodium
dodecyl sulfate-polyacrylamide gels and by the P2 antibody. In contrast, this protein was not detected in
mock-transfected cells. Deletion of DNA sequences containing ORF 2 blocked synthesis of the 41-kDa protein
in COS-7 cells. Reverse transcriptase-mediated PCRs indicated that splicing occurs near the C terminus of
ORF 2. Further studies indicated that LR RNA was alternatively spliced in latently infected cattle and that a
fraction of LR RNA was poly(A)1. Taken together, these studies suggested that a spliced LR transcript has the
potential to encode a 41-kDa protein.
Bovine herpesvirus 1 (BHV-1) is a significant viral pathogen
of cattle which can induce respiratory disease, abortion, or
occasionally encephalitis (reviewed in reference 28). Further-
more, BHV-1 is believed to be a causative agent of shipping
fever, or bovine respiratory complex. As a consequence of the
pathogenic potential of BHV-1, the cattle industry suffers
losses of millions of dollars per year. Like all members of the
alphaherpesvirus family, BHV-1 establishes a latent infection
in sensory ganglionic neurons of an infected host (15, 20–22).
The virus can persist in a latent state for the lifetime of the
infected host or can periodically reactivate. During reactiva-
tion, virus particles are synthesized and subsequently passed to
other susceptible cattle. In essence, latently infected animals
serve as a reservoir for the virus and are primarily responsible
for transmission of the virus.
During a primary infection of cattle, BHV-1 infects epithe-
lial cells of the upper respiratory tract or, in some instances,
the genital tract. Subsequently, virus enters the peripheral and
central nervous systems, where it establishes a latent infection
in sensory neurons (1, 20). A latent infection of BHV-1 can be
divided into at least three stages: (i) establishment of a latent
infection in sensory neurons, (ii) maintenance of the latent
state, and (iii) reactivation of latent virus. In contrast to the 70
to 80 viral genes expressed during a lytic infection of bovine
cells, it is clear that viral gene expression is severely impaired
during a latent infection (20–22). One small region of the
genome is transcriptionally active in latently infected neurons,
and this region is designated the latency-related gene (LRG).
The results of previous studies revealed that expression of the
LRG is controlled by a 980-nucleotide (980-nt) fragment (3, 4,
16). During a productive infection in bovine cells, the tran-
scriptional start site for LR RNA is downstream of two TATA
elements (3). DNA sequence analysis revealed that two major
open reading frames (ORFs) exist within the LRG (18).
Although the LR promoter has been analyzed in consider-
able detail (3, 4, 16), it is not known whether a protein is
synthesized from the LRG. The aim of this work was to deter-
mine if the LRG can encode a protein. For this purpose, we
inserted the LRG into mammalian expression vectors. Trans-
fection of these constructs into COS-7 cells resulted in ex-
pression of a 41-kDa protein which could be detected by an
antipeptide antibody and by silver staining of protein gels.
However, the protein was not detected in a construct contain-
ing a deletion at the 59 end of the LRG. Synthesis of a similar-
size protein was also detected during a lytic infection. Reverse
transcriptase-mediated PCR (RT-PCR) analysis indicated that
the LR RNA is spliced near the C terminus of ORF 2 and has
novel 59 termini in latency. Furthermore, a fraction of LR
RNA is poly(A)1. Taken together, these results suggest that a
spliced LR RNA is translated into a 41-kDa protein encoded
by ORF 2.
MATERIALS AND METHODS
Virus and cells. COS-7 cells (American Type Culture Collection, Rockville,
Md.) were grown in Earle’s modified Eagle’s medium supplemented with 5%
fetal bovine serum. Bovine turbinate (BT) cells were maintained as described
previously (16). The Cooper strain of BHV-1 was obtained from the National
Veterinary Services Laboratory, Animal and Plant Health Inspection Services,
Ames, Iowa (16). BT cell monolayers were infected with the Cooper strain of
BHV-1 (multiplicity of infection, 5 PFU per cell) 24 h prior to preparation of cell
lysates or at the indicated time before RNA extraction.
Virus infection and preparation of cell lysates. After infection, BT cells were
washed once with phosphate-buffered saline (PBS) and cells were collected in
PBS with a disposable cell scraper. The cells were then centrifuged in a micro-
centrifuge (16,000 3 g, 5 min, 48C) and suspended in lysis buffer (10 mM
Tris-HCl buffer [pH 7.2], 50 mM NaCl, 1 mM EDTA) containing protease and
phosphatase inhibitors (10 mg of aprotinin per ml, 10 mg of soybean trypsin
inhibitor per ml, 100 mg of leupeptin per ml, 10 mM phenylmethylsulfonyl
fluoride [PMSF], 10 mM iodoacetamide, 20 mM sodium Pi, 50 mM sodium
fluoride, and 1 mM sodium o-vanadate; Sigma, St. Louis, Mo.). The lysis buffer
was prepared from stock solutions immediately before use. An equal volume of
hot 5% sodium dodecyl sulfate (SDS) solution (1008C) was added to the cell
suspension, which was then vortexed briefly and boiled for 5 min. The cell lysates
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were then centrifuged for 5 min (16,000 3 g), and the supernatant was collected
and stored in small aliquots at 2208C.
Plasmids. A SalI site was first introduced into pcDNAI/Amp (Invitrogen, San
Diego, Calif.) by inserting a SalI linker at the XbaI site, and this plasmid was
designated pCDNAI/Amp-SalI. The 2.0-kb HindIII-SalI fragment containing the
entire LR promoter and gene was purified on a 5% polyacrylamide gel and
cloned into the unique HindIII-SalI site of pCDNAI/Amp1-SalI (23). This con-
struct was termed pcDNA/LR-1. pcDNA/LR-1D SphI was constructed by delet-
ing a 1.0-kb SphI fragment from pcDNA/LR-1.
The HindIII-SalI fragment has three SphI sites, at nt 774, 805, and 1773 (see
Fig. 1 and 4). To delete the 31-bp fragment between the first two SphI sites and
introduce a SphI stop linker, the HindIII-SalI fragment was digested with XbaI
and PstI. The 457-bp XbaI-PstI fragment (nt 524 to 981) was purified and cloned
into phagemid Bluescript II SK1 (Stratagene, La Jolla, Calif.). The resulting
construct was designated SK/LR-1. A SphI stop linker (Sigma) was introduced
into SK/LR-1 to create SK/LR-3. The HindIII-SalI fragment was purified from
pcDNA/LR-1 and digested with PstI-SalI, and the 1,019-bp PstI-SalI fragment
was cloned into SK/LR-3 to generate SK/LR-4, which contains the 1,544-bp
XbaI-SalI fragment of the original 2.0-kb HindIII-SalI fragment in which a SphI
stop linker has been introduced. The XbaI-SalI fragment was purified from
SK/LR-4 and cloned into pcDNA/LR-1, which was digested with XbaI-SalI to
release its XbaI-SalI fragment to create pcDNA/LR-1 Stop. pcDNA/LR-1 Stop
thus contains the HindIII-SalI fragment of the LR promoter and gene from
which the 31-bp fragment between the first two SphI sites (nt 778 and 801) was
deleted and into which a SphI stop linker was inserted. For a diagram of the
respective LR constructs, see Fig. 4A.
Transfection. COS-7 cells were transfected with the different LR constructs by
calcium phosphate precipitation (13). Eighteen hours prior to transfection, cells
were plated at a density of 33 105/100-mm-diameter dish. Generally, 10 to 15 mg
of plasmid DNA was used for each 100-mm-diameter dish. At 24 and 48 h
posttransfection, cell monolayers were washed with PBS and cell lysates were
prepared as described above.
Antibodies, immunoprecipitation, and Western immunoblotting. For immu-
nodetection of proteins, rabbit antisera raised against synthetic peptides (18
amino acids long; Chiron Corporation, Clayton, Australia) corresponding to
sequences near the N terminus and C terminus of LR ORF 2 were used. In
addition, a synthetic peptide derived from the sequences near the N terminus of
LR ORF 1 was used. These peptides were conjugated to diphtheroid toxoid and
injected into rabbits for production of antisera according to standard procedure.
The protein concentrations of cell lysates were determined (2), and samples (50
mg) were electrophoresed by SDS–10% polyacrylamide gel electrophoresis
(PAGE) and electroblotted onto Immobilon P membranes (Millipore, Bedford,
Mass.) by using a Trans-Blot semi-dry transfer cell (Bio-Rad, Richmond, Calif.)
for 1 h at 20 V. The filter was blocked for 2 h at 48C in PBS (0.53) containing
5% powdered milk, 1.0% bovine serum albumin (Sigma), 1.0% fetal calf serum,
7.5% glycine (Sigma), and 0.1% Tween 20. The filter was then washed (30-min
wash, four times) in PBS (0.53) containing 1.0% fetal calf serum and 0.1%
Tween 20. Primary antibody was used at a 1:5,000 dilution in wash buffer (0.53
PBS containing 1.0% fetal calf serum and 0.1% Tween 20), and the blot was
incubated overnight at 48C. The blot was incubated with wash buffer (30-min
wash, six times) at room temperature. Horseradish peroxidase-conjugated anti-
rabbit whole antibody raised in donkeys (Amersham Corp., Arlington Heights,
Ill.) was used as a secondary antibody at a 1:1,000 dilution in wash buffer, and the
blot was incubated at 48C for 2 h. After four washes at room temperature (30 min
each wash), the blot was developed with the ECL chemiluminescence system
(Amersham) and then exposed to XAR5 film (Kodak, Rochester, N.Y.).
For preparation of cell lysates to be used in immunoprecipitations, infected BT
cells or transfected COS-7 cells were washed once with PBS, 1 ml of lysis buffer
(50 mM Tris-HCl [pH 8.0], 125 mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40, 1
mM dithiothreitol, 2 mM Na-orthovanadate, 10 mM PMSF, 10 mM NaPPi, and
10 mg each of soybean trypsin inhibitor, leupeptin, and aprotinin per ml) was
added per 100-mm-diameter dish, and cells were collected with a cell scraper.
The cell suspension was shaken for 30 min at 48C and then centrifuged for 5 min
(16,000 3 g) at 48C. The supernatant was collected and stored in small aliquots
at 2208C. Cell lysates (200 mg) precleared with normal rabbit serum were
incubated with P2 antibody (1:1,000 dilution in PBS) for 3 h at 48C. Immune
complexes were collected by adsorption with 25 ml of protein A-Sepharose
(Pharmacia, Piscataway, N.J.). The beads were sedimented and washed three
times with 10 mM Tris-HCl buffer containing 50 mM NaCl, 1 mM EDTA, and
0.5% Nonidet P-40. The proteins were separated by SDS-PAGE, and Western
blots were incubated with a 1:2,500 dilution of primary antibody as described
above. In blocking experiments, P2 antibody was preincubated with P2 peptide
(10 to 40 nmol) for 1 h at 378C and the immunoprecipitation reaction was carried
out as described above.
Isolation of RNA. RNA from trigeminal ganglia was prepared as described by
Chomczynski and Sacchi (5), with slight modifications. Trigeminal ganglia from
latently infected or uninfected cattle (a generous gift from F. Osorio) were
frozen at2708C. The infection of cattle and extraction of trigeminal ganglia have
been described elsewhere (11). Frozen tissue (1 to 2 g) was minced. Subse-
quently, the tissue was placed in a guanidine-isothiocyanate solution (4 M gua-
nidine thiocyanate, 25 mM sodium citrate [pH 7.0], 0.5% sarcosyl, and 14 mM
b-mercaptoethanol) and homogenized for 10 to 15 s with a Brinkman Polytron
tissue grinder. The tissue grinder probe had previously been incubated in 1 M
KOH overnight and rinsed extensively with sterile diethyl pyrocarbonate-treated
water (to eliminate RNase activity). Grinding was repeated until the tissue was
completely suspended (once or twice). Two phenol extractions were performed
to ensure that the RNA was free of protein. RNA concentrations were deter-
mined spectrophotometrically (260 nm). From 1 or 2 g of tissue, approximately
1 to 2 mg of RNA was obtained. Aliquots of RNA (50 mg) were suspended in 1
volume of Tris-EDTA containing 0.3 M Na acetate, 2.5 volumes of ethanol were
added, and the samples were stored at 21208C. RNA extraction from tissue
culture was performed essentially as described by Chomczynski and Sacchi (5).
Identification of splicing in LR RNA. RNA samples were treated with 2 U of
DNase I (RNase free) per mg of RNA for 20 min at 208C and then ether
extracted and ethanol precipitated. This treatment eliminates contaminating
DNA but does not interfere with RT activity (24). Five micrograms of total RNA
and the proper amount of primer (0.75 mM for sequence-specific primer or 2.5
mM for T(12–18); both final concentrations), in 4 ml of Tris-EDTA, were incu-
bated at 658C for 5 min and chilled on ice (denaturation). Sixteen microliters of
ice-cold RT mix (20 mM Tris-HCl [pH 8.3], 50 mM KCl, 2.5 mM MgCl2, 100 mg
of bovine serum albumin per ml, 1 mM dithiothreitol, 0.5 mM each deoxynucleo-
side triphosphate, 10 U of RNasin [Promega, Madison, Wis.], and 100 U of
RNase H2 RT [Stratagene]) was added. The reaction mixture was incubated at
208C for 10 min and then at 458C for 60 min. Reverse transcription was termi-
nated by incubation at 958C for 5 min. An aliquot (2.5 ml) of the RT reaction
mixture was used for PCR. PCRs were carried out with 50 ml of 13 commercial
PCR buffer–1.0 mM MgCl2–10% glycerol–200 mM each deoxynucleoside
triphosphate–1 mM each primer–1 U of Taq polymerase. The locations of prim-
ers used for amplification are shown in Fig. 6. Amplification was carried out for
40 cycles by denaturing at 958C for 1 min, annealing at 658C for 1 min, and
extension at 728C for 3 min in the first cycle, increasing 2 s per cycle. Upon
completion of the last cycle, the reaction mixtures were further incubated at 728C
for 7 min in order to ensure complete extension of the amplified products. All
PCRs were hot started (components were mixed at 48C, and the reaction mixture
was placed in a preheated 958C heat block) after 3 min of denaturation at 958C.
The use of RNase H2 RT and a high temperature for reverse transcription as
well as 10% glycerol and Hot start in the PCR mixtures allows amplification
through RNA regions of complex secondary structure. Amplified products were
resolved by agarose gel electrophoresis, blotted onto a nylon membrane, and
hybridized to probe 1. After autoradiography, the membranes were stripped and
rehybridized with probe 2.
The primers used to identify the LR splice site within ORF 2 are as follows.
Primer 1815 (59-GACGAGACCCCCGATTGCCG-39) is antisense to LR RNA
and was used to prime total LR RNA cDNA synthesis. Primer 1629 (59-GGC
CCGCCGGAGAAGAAGGACAGAGT-39) is antisense to LR RNA and was
used for PCR amplification. Primer 872 (59-AGGCTGGGGGTCGCAAATAC
ACGGC-39) has the same sense as LR RNA and was used for PCR amplifica-
tion. To prime poly(A)1 RNA, a commercial poly(dT) primer which is 12 to 18
nt long (Invitrogen) was used. The hybridization probes used for identifying
spliced LR RNA were probe 1, from nt 890 to 920 (59-GGTGCGGTGTGGT
GGCCTGCGGG-39), and probe 2, from nt 1606 to 1585 (59-AGTTAGAC
CGCGCCCGGACCCC-39).
Mapping the 5* end of LR RNA. Total RNA extracted from infected BT cells
(2 mg) or latently infected trigeminal ganglia from cattle (5 mg) was reverse
transcribed and amplified with a RACE (rapid amplification of cDNA ends)-
PCR kit according to the instructions of the manufacturer (Clontech, Palo Alto,
Calif.). The primers used for RACE-PCR are as follows. Primer RI was used for
cDNA synthesis, is antisense to LR RNA, and is located between nt 913 and 942
(59-TCCCCGCCCACCCACTCCGCGACCCGCAGC-39) (upstream primer:
the complement to the anchor oligonucleotide provided by the Amplifinder
RACE kit [Clontech]). Primer RII is antisense to LR RNA and is located
between positions 894 and 913 (59-CCCACCACACCGCACCGCCG-39). Am-
plified products were hybridized with an oligonucleotide complementary to po-
sitions 811 to 841 (59-GCGAGCAGTTACTTTCGGTTTGGGGATGACA-39),
designated probe RIII.
Mapping the 3* end of LR RNA in BHV-1. Total RNA extracted from either
lytically infected BT cells (2 mg) or latently infected trigeminal ganglia from
cattle (5 mg) was reverse transcribed and PCR amplified. cDNA synthesis was
primed with 1 mg of T(12–18). The primers used to map the 39 terminus of LR
RNA were as follows: L3A primer pair, upstream sense primer from nt 1672 to
1693 (59-CGCTCCCCTTCGTCCCTCCTCA-39) and downstream antisense
primer complementary to nt 1835 to 1815 (59-GACGAGACCCCCGATTGC
CG-39); L3B primer pair, upstream sense primer from nt 1755 to 1775 (59-
TTCTCTGGGCTCGGGGCTGC-39) and downstream antisense primer com-
plementary to nt 1924 to 1947 (59-AGAGGTCGACAAACACCCGCGGT-39);
and L3C primer pair, upstream sense primer from nt 1856 to 1875 (59-TGG
GGGGCGCGGAAACTG-39) and downstream antisense primer complemen-
tary to nt 2003 to 2021 (59-AGTCGAGGCGCACGCGGG-39). These primers
also amplify IE 2.9/E 2.6, which overlaps (in the opposite sense) the bulk of LR
RNA (see Fig. 6). PCR conditions were as follows: denaturing at 958C for 1 min,
annealing at 658C for 1 min, and extension at 728C for 3 min in the first cycle and
increasing 2 s per cycle. All PCRs were hot started after 3 min of denaturation
at 958C. Glycerol (10%) was added to the buffer to disrupt secondary structure.
The MgCl2 concentrations were 1.5 mM for primer pair L3C and 1.0 mM for
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primers pairs L3A and L3B. Amplifications were carried out for 40 cycles. Upon
completion of the last cycle, the reaction mixtures were further incubated at 728C
for 7 min to ensure complete extension of amplified products. Amplified prod-
ucts were electrophoresed in a 2% agarose gel.
RESULTS
Immunodetection of 41-kDa protein in BHV-1-infected BT
cells. When DNA sequences comprising the LRG were ana-
lyzed for protein coding regions, two major ORFs were iden-
tified (LR ORF 1 and LR ORF 2) (18) (Fig. 1). The first
in-frame ATG of LR ORF 2 is 51 nt from the start site of
transcription, and the ATG of LR ORF 1 is 444 nt from the
start site of transcription. After the three stop codons at the 39
terminus of LR ORF 2, there is not another stop codon until
DNA sequences near the SalI site. In reading frame C, there is
a long ORF but no initiating methionine at its amino terminus.
Since LR ORF 2 is the first ORF after the start site of tran-
scription, and since its initiating methionine is in proper con-
text for translation (17), it appears to have a higher probability
of being expressed relative to LR ORF 1. Two peptides from
LR ORF 2 and one from LR ORF 1 were synthesized and
designated P1 through P3 (Fig. 1B). To enhance immunoge-
nicity of the respective peptides, each 18-amino-acid peptide
was conjugated to the diphtheroid toxoid. The conjugated pep-
tides were injected into rabbits, and subsequently several
booster injections were given to induce antibodies against the
peptides. Each antibody had a titer of .10,000 for its respec-
tive peptide as determined by enzyme-linked immunosorbent
assay (data not shown).
Antibodies directed against P1, P2, or P3 were used to de-
termine if proteins were synthesized from the LRG during a
productive infection. BT cells were infected with BHV-1 (5
PFU per cell), and whole-cell lysates were prepared at 24 and
48 h postinfection. At 48 h postinfection, the P2 antibody
recognized a 41-kDa protein (Fig. 2, panel P2, lane 3). In
addition, several smaller proteins were recognized by the P2
FIG. 1. Organization of the LRG and protein coding regions. (A) Diagram of LRG plus partial restriction enzyme map. Positions of immediate-early transcripts
and LR transcript are shown (arrows). IE 2.9 is the 2.9-kb immediate-early transcript derived from IEtu1, and E 2.6 is the 2.6-kb early transcript (26, 27). IE 2.9 and
E 2.6 are translated into identical proteins which have transcriptional transacting activity; the position of the stop codon (F) is indicated. The location of the two
overlapping TATA boxes, start site of LR transcription, and neuron-specific enhancer in the LR promoter were described previously (3, 4, 16). Translation of LR DNA
sequences was conducted by using the Wisconsin Genetics Computer Group sequencing package. The two major ORFs which were previously described (18) are shown.
The other regions which have the potential to encode a protein (o andf) are in reading frames B and C, respectively, but do not have methionine residues at their
amino termini. Stop codons following the reading frames are indicated (w). (B) Predicted amino acid sequence of LR ORF 1 and LR ORF 2. Oligopeptides P1 to P3
derived from LR ORF 1 and LR ORF 2 (boldface and underlined) were synthesized, conjugated to the diphtheroid toxoid, and injected into rabbits to generate specific
antiserum.
FIG. 2. Western blot analysis of BHV-1-infected BT cell lysates with P1, P2,
and P3 antibodies. BT cell monolayers were infected with the Cooper strain of
BHV-1 (multiplicity of infection, 5). At 0, 24, and 48 h postinfection (lanes 1 to
3, respectively), cell lysates (50 mg) were electrophoresed by SDS–10% PAGE,
electroblotted onto Immobilon P membranes, and analyzed by immunoblotting
with antibodies generated in rabbit against the synthetic ORF peptides. Horse-
radish peroxidase-conjugated anti-rabbit whole antibody raised in donkeys (Am-
ersham Corp.) was used as a secondary antibody, and the blot was developed by
using the ECL chemiluminescence system (Amersham) according to the instruc-
tions of the manufacturer.
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antibody. At 24 h postinfection, the 41-kDa protein was nearly
undetectable but the smaller virus-specific proteins were
present. In several independent experiments, the P3 or P1
antibody did not react with any viral or virus-induced protein
(Fig. 2, panels P1 and P3). The small protein in panel P1, lane
2, was not routinely observed, suggesting that this was the
result of a cross-reaction with a viral or cellular protein.
To examine the specificity of the P2 antibody, blocking ex-
periments were performed with peptide P2. After the various
cell lysates were immunoprecipitated with the P2 antibody,
samples were electrophoresed by SDS-PAGE, proteins were
transferred to nitrocellulose, and the Western blot was probed
with P2 antibody. Addition of the P2 peptide to immunopre-
cipitation reaction mixtures prevented immunoprecipitation of
the 41-kDa protein at 24 or 36 h postinfection (Fig. 3A, lanes
3 and 5). In contrast, the 41-kDa protein was readily detected
if the peptide was not included in the immunoprecipitation
assay (Fig. 3A, lane 6). Although the 41-kDa protein has been
consistently detected during a productive infection of bovine
cells, smaller proteins were also detected. The number, size, or
intensity of these smaller proteins differed from experiment to
experiment, suggesting that they are proteolytic degradation
products of the 41-kDa protein. If a cocktail of protease and
phosphatase inhibitors (10 mg of aprotinin per ml, 10 mg of
soybean trypsin inhibitor per ml, 100 mg of leupeptin per ml, 10
mM PMSF, 10 mM iodoacetamide, 20 mM sodium Pi, 50 mM
sodium fluoride, and 1 mM sodium o-vanadate) was not in-
cluded in the lysis buffer, the relative intensity of the 41-kDa
protein decreased and the intensity of the smaller proteins
increased. As expected, normal serum did not recognize the
41-kDa protein in mock-infected or infected BT cells (Fig. 3B).
In summary, these findings suggested that either (i) LR ORF
2 encodes a protein during a productive infection, (ii) the P2
antibody cross-reacted with another viral protein, or (iii) the P2
antibody reacted with a cellular protein induced by viral infection.
Immunodetection of 41-kDa protein in transfected cells. To
determine if the LRG encodes the 41 Kd protein, restriction
fragments containing LRG sequences were inserted into a
mammalian expression vector (pcDNAI/Amp; Fig. 4A). Since
COS-7 cells express the simian virus 40 large T antigen, plas-
mids containing the simian virus 40 origin of replication should
replicate in COS-7 cells (12), thus allowing for efficient expres-
sion of LRG products. A novel 41-kDa protein was detected by
silver staining an SDS-polyacrylamide gel which contained
COS-7 cell extracts transfected with pcDNA/LR-1 (Fig. 4B,
lane 4). To further demonstrate that the 41-kDa protein was
encoded by ORF 2, a 1.0-kb SphI fragment of the LRG was
deleted from pcDNA/LR-1. In effect, this deletion eliminated
LR ORF 2 but retained the LR promoter. The 41-kDa protein
was not present in cell lysates prepared from cells transfected
with pcDNA/LR-1D SphI (Fig. 4B, lane 3). A similar-size pro-
tein was also present in COS-7 cell lysates transfected with
constructs containing the XbaI-SalI fragment of the LRG (data
not shown).
Forty-eight hours after COS-7 cells were transfected with
pcDNA/LR-1, a 41-kDa protein was detected by the P2 anti-
body (Fig. 4C, lanes 1 and 3). In addition, several smaller
proteins migrating between 21 and 35 kDa were detected. A
41-kDa protein was not detected when cells were transfected
with a construct that has a mutation at the amino terminus of
LR ORF 2 (pcDNA/LR-1 Stop; Fig. 4C, lane 2). Addition of
the P2 antibody to the reaction mixture inhibited immunopre-
cipitation of the 41-kDa protein (Fig. 4C, lanes 4 and 5),
suggesting that binding of the antibody to the 41-kDa protein
was specific. The P1 or P3 antibody did not react with the
41-kDa protein in cells transfected with pcDNA/LR-1 (data
not shown). The simplest interpretation of these experiments is
that the P2 antibody recognized a 41-kDa protein encoded by
LR ORF 2.
Structure of LR RNA in latently infected cattle and produc-
tively infected bovine cells. To better understand LR RNA
structure, total RNA was prepared from BT cells infected with
5 PFU of BHV-1 per cell (5 or 7.5 h postinfection) or from
trigeminal ganglia of calves latently infected with BHV-1, and
LR RNA was detected by RT-PCR. As controls, RNAs were
prepared from mock-infected BT cells and trigeminal ganglia
of an uninfected calf.
The 59 termini of LR RNAs in latently infected cattle were
localized by RACE-PCR (Invitrogen). During a latent infec-
tion, two RACE-PCR products (approximately 380 and 610
bp) were detected (Fig. 5A). Thus, two unique 59 termini were
located near nt 524 and near nt 310. In contrast, two smaller
bands (approximately 100 and 200 bp) were observed during a
productive infection (Fig. 5A), which is in agreement with
previous results obtained using primer extension (3). This re-
sult suggested that transcription of LR RNA was regulated by
neuron-specific transcriptional regulatory elements residing
upstream of the promoter utilized during a lytic infection.
The studies presented in previous sections indicated that a
protein with an apparent molecular mass of 41 kDa was syn-
thesized from LR ORF 2 (Fig. 2 to 4). Inspection of LR ORF
2 revealed that it is 181 amino acids long and thus should
encode a protein with a molecular mass of 22.8 kDa (Fig. 1).
Although posttranslational modification of proteins can lead to
slower mobility on SDS-polyacrylamide gels, it is not likely that
the apparent molecular mass would be increased 1.7 times. All
three LR reading frames contain potential protein coding do-
mains, without initiating methionines, which could be utilized
to produce a larger protein if splicing occurred near the car-
boxy terminus of LR ORF 2 (Fig. 1). Finally, analysis of LRG
DNA sequences indicates that several potential splice acceptor
donor sites are 39 and 59 to the three stop codons at the carboxy
terminus of LR ORF 2 (data not shown). To test whether the
RNA was spliced, a primer located near P2 (primer 872) and
one downstream of the three stop codons at the end of ORF 2
were chosen to amplify LR RNA (see Fig. 6 for locations of
primers). The expected size of the amplified product was 757
bp. When cDNA synthesis was primed with an LR RNA-
specific primer (primer 1815), several bands smaller than 757
bp were detected after PCR, suggesting that the LR RNA was
spliced (Fig. 5B). Since the amplified products hybridized to
probes 1 and 2 (Fig. 6 and data not shown), they were not the
result of mispriming. The distributions of these bands were
FIG. 3. Western analysis of BHV-1-infected BT cell lysates immunoprecipi-
tated with P2 antibody (1:1,000 dilution) or P2 antibody preincubated with P2
peptide (10 nmol) for 1 h at 378C prior to use (A) or immunoprecipitated with
normal rabbit serum (B). After immunoprecipitation, proteins were separated by
SDS-PAGE and immunodetection was performed with a 1:2,500 dilution of
primary antibody as described in the legend to Fig. 2. Lanes 1, mock-infected BT
cell lysate; lanes 2 to 6, BT cell lysates after 1 h of incubation with BHV-1 (lanes
2); at 36 h postinfection, with or without P2 antibody preincubated with peptide
antigen conjugated to diphtheroid toxoid (lanes 3 and 4, respectively); and at 24
h postinfection, with or without P2 antibody preincubated as for lane 3 but with
peptide antigen (lanes 5 and 6, respectively).
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different in lytic and latent infections. In contrast, when cDNA
synthesis was primed with a poly(dT) oligonucleotide and then
LR cDNA was amplified with primers 872 and 1629, one prom-
inent band smaller than 757 bp was detected in a latent or lytic
infection (Fig. 5C). In summary, these studies suggested that
LR RNA was spliced near the C terminus of LR ORF 2, that
a fraction of LR RNA was poly(A)1, and that the splicing of
poly(A)1 and poly(A)2 LR RNAs was different.
To localize the 39 terminus of LR RNA, three sets of primers
located near the putative end of the LR RNA were designed
and used for RT-PCR (for locations of primers, see Fig. 6).
Previous studies relied on in situ hybridization to map the 39
terminus of the LR RNA (20, 21). These studies did not take
into account whether LR RNA was poly(A)1 or poly(A)2, nor
were their methods as sensitive as RT-PCR. Since the three
sets of primers used for these studies would also amplify IE
2.9/E 2.6, which is antisense to LR RNA (18, 27) (Fig. 1 and 6),
RNA extracted from latently infected cattle was used. As ex-
pected, IE 2.9/E 2.6 RNA was not detected in latently infected
cattle when primers which amplify IE 2.9/E 2.6 were used (Fig.
7, primer L3C). For all of these experiments, cDNA synthesis
was done with a T(12–18) primer. LR RNA was amplified when
L3A or L3B primers were used (Fig. 7). In contrast, L3C
primers did not amplify RNA prepared from latently infected
cattle. As expected, all three primers detected RNA prepared
from productively infected BT cells. Southern blotting also
confirmed that the amplified products were derived from the
LR region, and samples lacking RT were consistently negative
(data not shown). In summary, these studies demonstrated that
the 39 terminus of LR RNA was located between positions
1948 and 2018.
DISCUSSION
In this study, experiments to identify and characterize LRG
products were conducted. A small fraction of LR RNA was
FIG. 4. Detection of 41-kDa protein in COS-7 cells transfected with plasmids containing LRG. (A) LRG constructs used in this study. pcDNA/LR-1 contains the
full-length 2.0-kb LR promoter and gene; pcDNA/LR-1D SphI was constructed by deleting a 1.0-kb SphI fragment from pcDNA/LR-1; and pcDNA/LR-1 Stop was
constructed by introducing a SphI stop linker at the first SphI site (nt 778). See Fig. 1 for a map of LRG and Materials and Methods for details of plasmid constructs.
(B) Silver staining of an SDS-polyacrylamide gel to detect protein encoded by ORF 2. COS-7 cells were transfected with the respective LR constructs, cell lysates were
prepared 48 h posttransfection, proteins were separated by SDS-PAGE as described in the legend to Fig. 2, and the gel was silver stained. Lane 1, mock-transfected-cell
proteins; lane 2, pcDNAI/Amp1; lane 3, pcDNA/LR-1D SphI; lane 4, pcDNA/LR-1. The position of the 41-kDa protein is indicated (square). (C) Immunoprecipitation
and Western analysis of COS-7 cell lysates with P2 antibody transfected with different LR constructs. P2 antibody (1:1,000 dilution) or P2 antibody preincubated with
P2 peptide was used in immunoprecipitation reactions. Immune complexes were collected by adsorption to protein A-Sepharose and analyzed by SDS-PAGE and
Western blotting as described in Materials and Methods. Lanes 1 and 3, COS-7 cell lysate transfected with pcDNA/LR-1; lane 2, pcDNA/LR-1 Stop; lane 4,
pcDNA/LR-1, with P2 antibody preincubated with P2 peptide antigen (10 nmol); lane 5, same as for lane 4 but with 40 nmol of antigen used; lane 6, pcDNAI/Amp
(blank expression vector). The position of the 41-kDa band is indicated (square).
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poly(A)1, and this RNA was spliced. Poly(A)2 RNA was al-
ternatively spliced, and distinct patterns of splicing were evi-
dent when RNA prepared from trigeminal ganglia of latently
infected cattle was compared with RNA from productively
infected bovine cells. Peptide antibodies directed against se-
quences near the amino terminus of LR ORF 2 detected a
41-kDa protein during the late stages of a productive infection,
suggesting that LR RNA is translated into a protein. The same
antibody detected a protein in COS-7 cells transfected with a
plasmid containing the LRG. Since LR RNA is the only viral
gene expressed during a latent infection, it is hypothesized that
the LR protein plays a role during some phase of a latent
infection.
The finding that antibodies directed against P2 but not P3
detected the 41-kDa protein (Fig. 2) suggested that amino
acids constituting P3 were not present in the protein or that
this region of ORF 2 was not immunogenic. RT-PCR analysis
demonstrated that splicing occurs near the C terminus of LR
ORF 2 (Fig. 5B and C), supporting the hypothesis that P3 was
not present in the 41-kDa protein. Since all three reading
FIG. 5. Comparison of LR RNA in latently infected cattle and productively infected bovine cells. Samples were electrophoresed in 2% agarose gels, and the DNA
was transferred to nylon. The Southern blots were probed with probe RIII (A), probe 1 (C), or probe 2 (23a). Radioactive probes were prepared by incubating the
respective oligonucleotides with [g-32P]ATP and polynucleotide kinase. Details of the respective probes are given in the text. (A) Mapping of the 59 end of LR transcript
in a latent infection by RACE-PCR. Lanes: MI, amplification of RNA extracted from mock-infected BT cells; 11 hpi, amplification of RNA extracted from lytically
infected BT cells at 11 h postinfection; TG1, amplification of RNA extracted from trigeminal ganglia of a cow latently infected with BHV-1; Control, amplification of
RNA extracted from trigeminal ganglia of an uninfected cow; NT, no-template control. (B) Amplification of total LR RNA by RT-PCR. Lanes: Latent (TG1) and
Latent (TG2), amplification of RNAs extracted from the trigeminal ganglia of two cows latently infected with BHV-1; Lytic (5 hpi), amplification of RNA extracted
from lytically infected BT cells at 5 h postinfection; Lytic (7.5 hpi), amplification of RNA extracted from lytically infected BT cells at 7.5 h postinfection; NT,
no-template control; BHV-1 DNA, positive control showing the expected full-length (757-bp) amplified product. (C) Amplification of polyadenylated LR RNA by
RT-PCR. Lanes are as described for panel B.
FIG. 6. Location of LR primers used to analyze LR RNA structure. (A) Restriction map of the LR promoter region, start site of LR transcription, termination of
IE 2.9/E 2.6, and position of neuron-specific enhancer (NSE) (3, 4, 16). The DNA sequences which encompass the amino acids used to synthesize P2 are from nt 841
to 895. The DNA sequences which encompass P3 are from nt 1261 to 1315. The first termination codon for LR ORF 2 is located at nt 1319 to 1321. The position of the
termination codon for IE 2.9/E 2.6 is indicated (solid circle). (B) Location of primers used for analyzing LR RNA. The primers are described in Materials and Methods.
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frames could be utilized after splicing occurs near the 39 ter-
minus of LR ORF 2, protein isoforms with the same N termi-
nus but different C termini could be generated by alternative
splicing. It is unlikely that the C terminus of LR ORF 1 is
utilized, because LR RNA terminates between positions 1948
and 2018 (Fig. 7) and LR ORF 1 terminates at position 2200
(18) (Fig. 1). Several putative splice acceptor donor sites exist
near the C terminus of LR ORF 2, lending support to the
hypothesis that a spliced RNA encodes the 41-kDa protein.
These studies also suggested that LR ORF 1 was not expressed
during a lytic infection, because the P1 antibody did not rec-
ognize a virus-specific protein (Fig. 2). The fact that the initi-
ating methionine of ORF 1 is 444 nt 39 from the initiating
methionine of ORF 2 would also favor expression of ORF 2.
Furthermore, the initiating methionine of ORF 2 appears to be
in proper context to be translated (17). In summary, several
lines of evidence suggested that LR ORF 2 was expressed
during a productive infection.
In addition to the P2 antibody recognizing a 41-kDa protein
in infected or transfected cells, the antibody also recognized
several other, smaller proteins (Fig. 2 to 4). Peptide blocking
studies suggested that the antibody specifically recognized
some of the smaller proteins (Fig. 3 and 4). These small pro-
teins and the 41-kDa protein were not detected when LR ORF
2 was disrupted (Fig. 4), arguing that the antibody was not
cross-reacting with other viral proteins. Addition of protease
inhibitors reduced the number and intensity of the smaller
bands, suggesting that these smaller proteins were the result of
proteolysis. Since the P2 antibody was directed against an
18-amino-acid peptide, this antibody may also cross-react
weakly with cellular proteins. On the basis of these observa-
tions, it is hypothesized that the 41-kDa protein encoded by
LR ORF 2 is labile because it is susceptible to proteolytic
degradation or undergoes processing. Experiments designed to
distinguish between these two possibilities are being pursued.
There are two major differences in the structure of LR
RNAs in latently infected cattle versus productively infected
bovine cells: (i) alternative splicing of poly(A)2 LR RNA oc-
curs, and (ii) the 59 termini of the LR RNAs were different.
Recent studies demonstrated that novel promoters in the LRG
are active in latently infected cattle and that these promoters,
in part, direct tissue-specific expression of LR RNA (7). These
novel promoter elements are 59 from the initiation sites de-
tected in latently infected cattle and thus are activated by
neuron-specific transcription factors. Numerous studies indi-
cated that LR RNA is predominantly localized to the nucleus
during a latent infection (20, 21). It is likely that the majority
of poly(A)2 RNA remains in the nucleus, where it is alterna-
tively spliced. Tissue-specific splicing factors exist (6, 14, 19),
suggesting that neuron-specific splicing of LR RNA occurs
during a latent infection. Neuron-specific splicing of neurexins,
cell surface proteins, is known to occur (25). a-Neurexin con-
tains five canonical sites of alternative splicing. Although each
splice site normally contains only two variants, some of the
splice sites have more than 10 variants. As a result, the total
number of neurexins in the brain exceeds 1,000 forms. Another
study has demonstrated that RT-PCR of the splice junction
sites of plasma membrane calcium ATPases, an alternatively
spliced mRNA, leads to additional spurious bands (29). Thus,
it is not clear if each band in Fig. 5B is due to an independent
splicing event. These studies clearly indicated that a small
fraction of LR RNA is poly(A)1 in latently infected cattle and
productively infected bovine cells, suggesting that this RNA
was translated (Fig. 5 and 7). Although poly(A)1 forms of LR
RNA appear to be spliced in similar fashions during latency
and productive infection, it will be necessary to sequence splice
junction sites to confirm this hypothesis and determine if the
poly(A)1 RNA is a template for translation. Efforts to clone
the cDNA products of LR RNA have not been successful
because this region was not stably maintained in bacteria. This
instability could be due to secondary structure of the LR RNA,
as suggested for herpes simplex virus type 1 (HSV-1) (9), or the
result of deleterious effects of LR protein expression in bacte-
ria.
Earlier studies suggested that HSV-1 encodes a latency-
associated antigen (LAA) (8). A role for LAA during latency
has not been reported. A mutant which contains stop codons in
the major ORF of the latency-associated transcript (LAT) can
establish, maintain, and reactivate from a latent infection (10),
suggesting that LAA is not required for a latent infection. A
comparison of ORF 2 of BHV-1 and the amino acid sequence
of the major ORF of HSV-1 LAT has not revealed extensive
amino acid similarities (data not shown). However, until a
function is assigned to this protein and functional domains are
identified, it may be difficult to compare the two ORFs.
The capacity of BHV-1 to remain latent in sensory neurons
of cattle and periodically reactivate is one of its most intriguing
biological properties. This complex virus-host interaction facil-
itates the spread of virus and complicates antiviral therapeutic
strategies. Since LR transcripts are the only viral RNAs ex-
pressed during a latent infection (18, 20, 21), they may regulate
some aspect of latency. Preliminary studies have not conclu-
sively demonstrated whether ORF 2 is expressed during a
latent infection (data not shown). Since only 1 to 10% of
sensory neurons are believed to be latently infected (20) and
since sensory neurons are a minor cell population in ganglia,
LR protein expression may be difficult to detect during latency.
It is also possible that only a subset of neurons which are
latently infected expresses the 41-kDa protein. Experiments
designed to determine a functional role for the 41-kDa protein
encoded by LR ORF 2 and whether it plays a role during latent
infection are under way.
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FIG. 7. Mapping of the 39 end of LR RNA. The primer pairs used for this
study (L3C, L3B, and L3A) are presented in Fig. 6. Lanes: BHV-1 103 and
BHV-1 104, DNA extracted from BHV-1 (103 and 104 genome copies, respec-
tively); Lytic 5 hpi, RNA extracted from BT cells at 5 h postinfection; TG 2 and
TG 1, RNAs extracted from trigeminal ganglia of two cows latently infected with
BHV-1; MI, RNA extracted from mock-infected BT cells; MWM, 100-bp ladder
(GIBCO-BRL).
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